BMS-906024

Search structure
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: DRL23N424R

Structure
InChI Key AYOUDDAETNMCBW-GSHUGGBRSA-N
Smile CN1C(=O)[C@@H](NC(=O)[C@H](CCC(F)(F)F)[C@H](CCC(F)(F)F)C(N)=O)N=C(c2ccccc2)c2ccccc21
InChI
InChI=1S/C26H26F6N4O3/c1-36-19-10-6-5-9-18(19)20(15-7-3-2-4-8-15)34-22(24(36)39)35-23(38)17(12-14-26(30,31)32)16(21(33)37)11-13-25(27,28)29/h2-10,16-17,22H,11-14H2,1H3,(H2,33,37)(H,35,38)/t16-,17+,22+/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C26H26F6N4O3
Molecular Weight 556.51
AlogP 4.35
Hydrogen Bond Acceptor 4.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 9.0
Polar Surface Area 104.86
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 39.0

Indications

Mesh Heading Maximum Phase Reference
Carcinoma; Carcinoma, Adenoid Cystic Phase 2 ClinicalTrials
Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Phase 1 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
CAS NUMBER 1401066-79-2
ChEBI 131164
ChEMBL CHEMBL4297269
DrugBank DB12006
EPA CompTox DTXSID30161234
FDA SRS DRL23N424R
SureChEMBL SCHEMBL12543868
ZINC ZINC000100285156
CONTENTS